mRNA |
AG-014699 |
GDSC1000 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
WP1130 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
NVP-ADW742 |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.6 |
mRNA |
selumetinib:decitabine (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
IPA-3 |
GDSC1000 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
Doxorubicin |
GDSC1000 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
GW-405833 |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |
mRNA |
Zibotentan |
GDSC1000 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.022 |
0.6 |